Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Barreto (Bad Nauheim, Germany). Nuclear miRNA/exosome-mediated transcriptional silencing within the context of TGFB1 signaling and Idiopathic Pulmonary Fibrosis.. 479

Member's Comments

No comment yet.

Related content which might interest you: Implication of FGFR4 and its ligands in Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung Year: 2016 Hypoxia-inducible factor pathway activation promotes bone-type collagen cross-linking in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 KCa3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway Source: International Congress 2014 – Cell biology 2014 Year: 2014 Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200 Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Identification of profibrotic cells in the Idiopathic Pulmonary Fibrosis (IPF) lung Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Metformin inhibits TGF-b-induced myofibroblast differentiation through AMPK activation Source: International Congress 2014 – Cell biology 2014 Year: 2014 Inhibition of the miRNA familiy miR-130 restores the expression of CDKN1A (p21) and ameliorates hypoxia-induced pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 FGF19, a potential innovative target in Idiopathic Pulmonary Fibrosis? Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 Pulmonary fibroblasts are affected by notch ligands in vitro Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 SRC family kinase inhibition reduces NOX4 expression in bronchial epithelial cells from Idiopathic Pulmonary Fibrosis patients Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 Elevated protein arginine methyltransferase 1 expression contributes to the pathogenesis of pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Analysis of candidate genes of phenotypic expression in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 The expression of the negative regulator of gene transcription SOCS3 as the crucial marker in the asthma pathogenesis Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 The role of Frizzled8 in idiopathic pulmonary fibrosis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 FGFR4 has pro fibrotic properties in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 The role of miR-21 and miR-34a in the fibrotic process of the lung Source: International Congress 2016 – IPF pathogenesis Year: 2016 Defective A20 signalling in CF: Anti-inflammatory action of gibberellins Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Acid sphingomyelinase, a novel pathway for pulmonary vasoconstriction. Activation by apoptotic T cell microparticles and Fas ligand Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014